Intravenous Lidocaine for Gut Function Recovery in Colonic Surgery
Assessed by RV005 · Statistician
Assessed on 11 Nov 2025
OverallReviewer's overall integrity assessment, derived from all research questions No concerns
DOI 10.1001/jama.2024.23898 (opens in new tab)
Resource ripekg:research-integrity-assessment/RIPEAB5F795FCD3B353B2
5 Research Questions · 2 Evidence Items
Q1.1 — Does the study have an associated retraction?
Rationale: Agree
Q1.2 — Does the study have an associated expression of concern or other relevant post-publication notice?
Rationale: Agree
Q1.3 — Do other studies by the research team highlight causes for concern?
Rationale: Agree
Q2.2 — Are there concerns relating to the timing or absence of study registration?
Rationale: Agree
Supporting Evidence (2)
Clinical Trial RegistrationSource: Clinical trial registry (e.g. ClinicalTrials.gov, ISRCTN)
Registration ID: ISRCTN52352431
Registry: ISRCTN
Registry Link: https://trialsearch.who.int/Trial2.aspx?TrialID=ISRCTN52352431 (opens in new tab)
Registration Date: 13/06/2018
Prospective:Whether the trial was registered before participant recruitment began Yes
Assessment Rationale:How INSPECT-AI determined the prospective registration status by comparing dates Registration date is on or before LLM recruitment start date.
Study Design EvidenceDates and timelines extracted by INSPECT-AI from the publication text
Recruitment Start: 13-08-2018
Recruitment Start Rationale:INSPECT-AI's reasoning for how it identified the recruitment start date Enrollment occurred from August 13, 2018, to April 11, 2023.
Recruitment End: 11-04-2023
Recruitment End Rationale:INSPECT-AI's reasoning for how it identified the recruitment end date Enrollment occurred from August 13, 2018, to April 11, 2023.
Study End: 10-08-2023
Study End Rationale:INSPECT-AI's reasoning for how it identified the study end date final follow-up was on August 10, 2023.
Overall — What is the overall integrity assessment of the study?
Rationale: No issues